REGDANVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 08:16:34 GMT 2025` Edited by `admin` on `Wed Apr 02 08:16:34 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	I0BGE6P6I6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

REGDANVIMAB

Official Name

English

CT-P59

Preferred Name

English

Regdanvimab [WHO-DD]

Common Name

English

CTP-59

Code

English

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL CT-P59 .GAMMA.-1 CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CT-P59 .LAMBDA.-CHAIN, DIMER

Common Name

English

regdanvimab [INN]

Common Name

English

CTP59

Code

English

Code System Code Type Description

FDA UNII

I0BGE6P6I6

Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025

PRIMARY

SMS_ID

300000023100

Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025

PRIMARY

INN

11883

Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025

PRIMARY

NCI_THESAURUS

C177084

Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025

PRIMARY

CAS

2444308-95-4

Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025

PRIMARY

WIKIPEDIA

Regdanvimab

Created by admin on Wed Apr 02 08:16:34 GMT 2025 , Edited by admin on Wed Apr 02 08:16:34 GMT 2025

PRIMARY

From	To
1_22	1_97
2_22	2_97
2_155	2_211
2_231	4_215
2_272	2_332
1_155	1_211
2_378	2_436
3_22	3_89
3_138	3_197
4_22	4_89
4_138	4_197
1_231	3_215
1_237	2_237
1_240	2_240
1_272	1_332
1_378	1_436

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_308
N	2_308

Related Record Type Details


					8R39BE7TJJ

SPIKE GLYCOPROTEIN (SARS-COV-2)

TARGET -> INHIBITOR

Interaction Type:

BINDING

Amount:


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->INHIBITOR

Amount:

Related Record Type Details


					I0BGE6P6I6

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID REMOVAL	[1_456] [2_456]	C-TERMINUS			LYSINE	K3Z4F929H6
AMINO_ACID_SUBSTITUTION	[1_1] [2_1]	N-TERMINUS			PIDOLIC ACID	SZB83O1W42

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL